Scientific advisers to the C.D.C. have been discussing the details of federal guidance on who qualifies for a Pfizer-BioNTech booster shot and why. A decision is expected on Thursday.
from NYT > Health https://ift.tt/3hWOX9O
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment